Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

BACKGROUND/AIMS: To evaluate the efficacy and safety of ledipasvir/sofosbuvir (LDV/SOF) therapy in hepatitis C virus (HCV)-infected Korean patients in a real clinical setting. METHODS: A total of 273 patients who received LDV/SOF therapy between May 2016 and February 2021 were consecutively enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soon Kyu, Lee, Sung Won, Lee, Hae Lim, Kim, Hee Yeon, Kim, Chang Wook, Song, Do Seon, Chang, U Im, Yang, Jin Mo, Yoo, Sun Hong, Kwon, Jung Hyun, Nam, Soon Woo, Kim, Seok-Hwan, Song, Myeong Jun, Lee, Jaejun, Yang, Hyun, Bae, Si Hyun, Han, Ji Won, Nam, Heechul, Sung, Pil Soo, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666263/
https://www.ncbi.nlm.nih.gov/pubmed/35618302
http://dx.doi.org/10.3904/kjim.2022.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666263/
https://www.ncbi.nlm.nih.gov/pubmed/35618302
http://dx.doi.org/10.3904/kjim.2022.013

Ejemplares similares